Asthma control over 3 years in a real-life study

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 348-355

  Lundbäck, Bo ^a,b,c   Rönmark, Eva ^a,b   Lindberg, Anne ^b,d   Jonsson, Ann Christin ^b   Larsson, Lars Gunnar ^b   James, Mark ^e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Combination; Control; Fluticasone propionate; Hyperresponsiveness; Salmeterol

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GASTROENTERITIS; HOARSENESS; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59349119176     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.015     Document Type: Article

References (29)

1. Jacoby D.B., Costello R.M., and Fryer A.D. Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol 107 (2001) 211-218
2. van den Toorn L.M., Prins J.-B., Jongste K.L., et al. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respir Med 99 (2005) 779-787
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2006 (http://www.ginasthma.com/GuidelinesResources.asp).
4. Jeffery P.K., Godfrey R.W., Adelroth E., et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 145 (1992) 890-899
5. Djukanovic R., Wilson J.W., Britten K.M., et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145 (1992) 669-674
6. Wilson J.W., Djukanovic R., Howarth P.H., et al. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 149 (1994) 86-90
7. van Essen-Zandvliet E.E., Hughes M.D., Waalkens H.J., et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Nonspecific Lung Disease Study Group. Am Rev Respir Dis 146 (1992) 547-554
8. Reddel H.K., Jenkins C.R., Marks G.B., et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 15 (2000) 226-235
9. Greening A.P., Ind P.W., Northfield M., et al. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344 (1994) 219-224
10. Woolcock A., Lundback B., Ringdal N., et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153 (1996) 1481-1483
11. Shrewsbury S., Pyke S., and Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 320 (2000) 1368-1373
12. Stoloff S., Poinsett-Holmes K., and Dorinsky P.M. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management. Pharmacotherapy 22 (2002) 212-226
13. Pauwels R.A., Lofdahl C.G., Postma D.S., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 (1997) 1405-1411
14. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164 (2001) 1392-1397
15. Bateman E.D., Boushey H.A., Bousquet J., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 179 8 (2004) 836-844
16. Lundback B., Ronmark E., Lindberg A., et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 100 (2006) 2-10
17. Lundbäck B., Nyström L., and Rosenhall L. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 4 (1991) 257-266
18. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 28 (1998) 3-10
19. Rönmark E., Lundbäck B., Jönsson E., et al. Incidence of asthma in adults - report from the Obstructive Lung Disease in Northern Sweden Study. Allergy 52 (1997) 1071-1078
20. Rönmark E., Jönsson E., and Lundbäck B. Remission of asthma in the middle aged and elderly: report from the Obstructive Lung Disease in Northern Sweden Study. Thorax 54 (1999) 611-613
21. Juniper E.F., Frith P.A., and Hargreave F.E. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 36 (1981) 575-579
22. Lundback B., Stjernberg N., Rosenhall L., et al. Methacholine reactivity and asthma. Allergy 48 (1993) 117-124
23. Jansen D.F., Rijcken B., Schouten J.P., et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am J Respir Crit Care Med 159 (1999) 924-931
24. Green R.H., Brightling C.E., McKenna S., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
25. Jayaram L., Pizzichini M.M., Cook R.J., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 3 (2006) 483-494
26. Sont J.K., Willems L.N.A., Bel E.H., et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 159 (1999) 1043-1051
27. Woolcock A.J. What are the important questions in the treatment of asthma?. Clin Exp Allergy Rev 1 (2001) 62-64
28. Bateman E.D., Clark T.J.H., Frith L., et al. Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal study. J Asthma 44 (2007) 667-673
29. Ward C., Pais M., Bish R., et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57 (2002) 309-316